Literature DB >> 32618241

Clinical and Laboratory Profile of Fatal Dengue Cases at a Tertiary Care Private Hospital in Mumbai, India.

Tanu Singhal1, Vatsal Kothari2.   

Abstract

Dengue-related mortality has significantly reduced with early and appropriate fluid resuscitation. However, we continue to see dengue-related fatalities in patients despite early intervention and advanced critical care support. This was a retrospective study conducted at a tertiary care private hospital in Mumbai, India. All patients dying of dengue in the calendar year 2017 were studied. Details related to age, gender, condition at presentation, laboratory parameters, treatment administered, and time to death were abstracted from case records. A total of 575 patients with a diagnosis of dengue were admitted to the hospital in 2017, of which 15 died (mortality rate 2.6%). Four patients died in the emergency medical unit; 11 patients who died after admission to the inpatient unit had multi-organ dysfunction at the time of presentation, with shock, severe liver dysfunction, and severe metabolic acidosis. Only 4/11 patients had hemoconcentration, and 10/11 patients had high white cell counts. In five patients where serum ferritin was performed, it was more than 40,000 ng/mL. Death occurred at a median time of 2 days after hospitalization despite good supportive care. Although there is scope for improvement of supportive care in these patients, it appears that other interventions are urgently needed to improve outcomes in severe dengue. This calls for more research into the immunopathology of dengue, evaluation of anti-inflammatory drugs, intravenous immunoglobulins, antivirals, and improved vaccines.

Entities:  

Mesh:

Year:  2020        PMID: 32618241      PMCID: PMC7470572          DOI: 10.4269/ajtmh.19-0425

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  7 in total

1.  Ferritin levels predict severe dengue.

Authors:  R Soundravally; B Agieshkumar; M Daisy; J Sherin; C C Cleetus
Journal:  Infection       Date:  2014-10-30       Impact factor: 7.455

Review 2.  Dengue: Moving from Current Standard of Care to State-of-the-Art Treatment.

Authors:  Victor C Gan
Journal:  Curr Treat Options Infect Dis       Date:  2014

3.  Hyperferritinaemia in dengue virus infected patients is associated with immune activation and coagulation disturbances.

Authors:  Cornelia A M van de Weg; Ralph M H G Huits; Cláudio S Pannuti; Rosalba M Brouns; Riemsdijk W A van den Berg; Henk-Jan van den Ham; Byron E E Martina; Albert D M E Osterhaus; Mihai G Netea; Joost C M Meijers; Eric C M van Gorp; Esper G Kallas
Journal:  PLoS Negl Trop Dis       Date:  2014-10-09

4.  The global distribution and burden of dengue.

Authors:  Samir Bhatt; Peter W Gething; Oliver J Brady; Jane P Messina; Andrew W Farlow; Catherine L Moyes; John M Drake; John S Brownstein; Anne G Hoen; Osman Sankoh; Monica F Myers; Dylan B George; Thomas Jaenisch; G R William Wint; Cameron P Simmons; Thomas W Scott; Jeremy J Farrar; Simon I Hay
Journal:  Nature       Date:  2013-04-07       Impact factor: 49.962

5.  Development of a Simple Clinical Risk Score for Early Prediction of Severe Dengue in Adult Patients.

Authors:  Ing-Kit Lee; Jien-Wei Liu; Yen-Hsu Chen; Yi-Chun Chen; Ching-Yen Tsai; Shi-Yu Huang; Chun-Yu Lin; Chung-Hao Huang
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

6.  Macrophage Activation Syndrome-Associated Markers in Severe Dengue.

Authors:  Hasliana Azrah Ab-Rahman; Hafiz Rahim; Sazaly AbuBakar; Pooi-Fong Wong
Journal:  Int J Med Sci       Date:  2016-02-17       Impact factor: 3.738

Review 7.  Dengue-associated hemophagocytic lymphohistiocytosis in an adult: A case report and literature review.

Authors:  Sang Mi Chung; Joon Young Song; Wonshik Kim; Min Joo Choi; Ji Ho Jeon; Seonghui Kang; Eunju Jung; Ji Yun Noh; Hee Jin Cheong; Woo Joo Kim
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.